The cell membrane is an insulator that does not let ions pass freely; they cross through protein structures that act as gates. Voltage-gated potassium channels make up some of these gates and open in response to changes in membrane voltage. The abbreviation Kv conveys both that the channel conducts potassium and that it is gated by voltage.
Understanding how these channels function is part of understanding how nerve and muscle cells work. However, humans have a large number of potassium channel genes, and the channels they produce resemble one another. It is therefore not easy to tell which channel a current observed in a cell comes from; this is where the main difficulty of the research lies.
In structural terms, four subunits come together to form these channels. They are arranged so that a pore is left in the middle, and the narrow section of that pore is selective enough to admit only the potassium ion. Along the edge of each subunit lies a region that senses changes in membrane voltage. When the voltage shifts, movement in these regions opens the pore.
How was the naming established?
The Kv family is divided into subgroups by number. The first figure, as in Kv1, Kv2 or Kv3, denotes the subfamily, while the figure after the dot points to the member within that subfamily. The name Kv1.3 is therefore read as the third member of the first subfamily.
A lower-case letter placed before the name states which species' gene the channel belongs to: r stands for a non-human rodent source, h for a human source. This is no trivial detail; one peptide is known to bind the same numbered channel with different potency in different species. In the report on our facility's reference batch, the target channels are stated as rKv1.1, rKv1.2 and hKv1.3, so two are of rodent and one of human origin.
The opening of these channels serves the cell as a kind of return mechanism. In an excitable cell, the membrane first turns positive rapidly; potassium leaving the cell then reverses that shift and restores the cell to an excitable state. How fast the channels open and how long they stay open determine how many signals the cell can fire in succession.
Where are these three subtypes found?
| Channel | Main location | Associated function |
|---|---|---|
| Kv1.1 | Central and peripheral nervous system, myelinated axon regions | Limiting excitability, regulating signal conduction |
| Kv1.2 | Nerve cells, frequently alongside Kv1.1 | Helping the membrane voltage return to its resting level |
| Kv1.3 | Immune cells, T lymphocytes in particular | Keeping the membrane voltage stable while the cell is activated |
In nerve cells, Kv1.1 and Kv1.2 frequently occur together within the same channel complex. That different subunits can assemble into a mixed channel explains why highly varied current profiles are seen in one and the same cell. This mixed architecture also makes it harder to attribute a current to a single gene.
Kv1.3 draws interest of its own, because it stands out in immune cells rather than in the nervous system. Once T lymphocytes are activated, calcium keeps entering the cell; for that entry to continue, the membrane must not become excessively positive, and the outflow of potassium maintains this balance. The channel's function is accordingly linked to the course of cell activation.
Besides the subunits, auxiliary proteins accompany the channel. Since these can alter how quickly the channel opens and where it sits in the membrane, two cells carrying the same gene may show different current profiles. This detail has to be kept in view before a current is attributed to one gene.
Why is the work done at subtype level?
The most direct route to understanding a channel's function is to silence it and measure how the cell's behaviour changes. If the available tool acts on several subtypes at once, however, it stays unclear which channel produced the observed change. Subtype-selective molecules remove that uncertainty.
Short-chain peptides obtained from scorpion venom are valuable at exactly this point. Some bind one particular subtype far more strongly than its neighbours and can be used in an experiment almost like a key. The structure and naming of the peptide family are set out in the article on α-KTx peptides, and the internal architecture that makes these peptides robust in the article on disulfide bridges.
Measurements are mostly made on electrophysiology set-ups. The channel of interest is transferred into a cell line or a suitable cell so that it is expressed from its own gene, and the channel current is then recorded directly. When the peptide is added to the medium, the fall in current becomes the measure of binding strength. If the current returns once the peptide is removed, the block is shown to be reversible.
Binding strength is expressed as a number. The peptide concentration is raised stepwise, the fall in current is measured and the concentration that halves the current is reported. The lower this value, the stronger the binding is taken to be; comparing the values obtained for one peptide across different channel subtypes reveals its selectivity. The cell system used and the conditions of the measurement are reported alongside the result.
Where does the research stop?
All of this work belongs to basic research and the development of molecular tools. That a channel has been linked to a particular cell function does not mean a molecule directed at that channel could be used for treatment; reaching such a conclusion would call for an entirely separate chain of research and approval. Nothing in this article constitutes treatment information.
The second limit lies with the material. Crude venom carries a great many components, so it is not used directly in channel experiments; it is fractionated first, the fraction of interest is identified and the work then continues with a single component. The material we supply stands at the beginning of that chain and is intended for research and industrial use only. Batch-level measurement results are published on the analysis page.
